Medical Devices: Page
-
Medtech M&A maintains momentum following decade-high 2025: PwC
Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.
By Nick Paul Taylor • June 17, 2026 -
Profile
‘Putting the body back together’ with MMI’s microsurgery robot
MMI built a robot to help surgeons perform microsurgical procedures with more control than is possible with the human hand alone.
By Susan Kelly • June 17, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
J&J commits $1B to expand contact lens production in Florida
The investment will add J&J’s manufacturing, packaging and distribution capabilities to meet growing demand for its contact lenses.
By Nick Paul Taylor • June 16, 2026 -
CMS proposes Medicare coverage expansion for TAVR
The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.
By Susan Kelly • June 16, 2026 -
In a first, Dexcom’s OTC glucose sensor is cleared for kids
The Stelo over-the-counter glucose monitor can now be used by children as young as two years.
By Elise Reuter • June 15, 2026 -
Medtronic closes Scientia Vascular takeover, continuing M&A streak
CEO Geoff Martha said the acquisition will enable “every neurovascular procedure to start with Medtronic.”
By Nick Paul Taylor • June 15, 2026 -
Top medtech stories from ADA’s Scientific Sessions
Dexcom, Abbott, MiniMed and Insulet featured upcoming technologies at the American Diabetes Association’s annual event. Catch up on news coming out of the conference.
By Elise Reuter • June 12, 2026 -
Penumbra’s FDA nod for clot removal tech a win for Boston Scientific
The stroke treatment could contribute about $100 million in incremental revenue over time to Boston Scientific, the buyer of Penumbra, one analyst said.
By Susan Kelly • June 12, 2026 -
Why Insulet thinks its fully closed loop system will stand apart from rivals
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes Care.
By Elise Reuter • June 11, 2026 -
Danaher closes $9.9B Masimo buyout
CEO Rainer Blair said Danaher has the money and “leadership bandwidth” to strike further deals across any of its three business areas.
By Nick Paul Taylor • June 11, 2026 -
GT Medical raises $100M for brain tumor tech after clinical trial success
Adoption of the GammaTile radiotherapy implant is growing, the company said, and the new funding round validates its potential to be a standard of care treatment.
By Susan Kelly • June 10, 2026 -
Bausch + Lomb to lay off employees in Missouri
The company plans to eliminate 119 positions by mid-December as part of a phased transfer of some production from the manufacturing site.
By Nick Paul Taylor • June 10, 2026 -
MiniMed is in the lead as diabetes tech firms focus on ‘fully closed loop’ systems, exec says
Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in developing automated insulin delivery systems that don’t require meal announcements.
By Elise Reuter • June 9, 2026 -
Medtronic set for Stealth AXiS expansion in Europe
With the CE mark for ear, nose and throat procedures, the advanced surgical navigation platform will be available to more surgeons across the region.
By Susan Kelly • June 9, 2026 -
Dexcom bolsters evidence for glucose sensors for Type 2 diabetes
New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said.
By Elise Reuter • June 9, 2026 -
Medtronic gets FDA nod for updated pulse oximetry system
The changes support accuracy across diverse patient populations, skin tones and clinical care settings.
By Nick Paul Taylor • June 9, 2026 -
3 takeaways from ADA
Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.
By Elise Reuter • June 8, 2026 -
Boston Scientific to build Indiana distribution center
The planned logistics site, near a principal manufacturing facility, will handle global distribution of Boston Scientific’s medical devices.
By Nick Paul Taylor • June 8, 2026 -
J&J, Medtronic back CereVasc’s $85M funding round
CereVasc is developing a minimally invasive treatment for the buildup of fluid in the brain.
By Nick Paul Taylor • June 5, 2026 -
Q&A
Olympus’ Keith Boettiger on robotic GI surgery push
Keith Boettiger, head of Olympus’ gastrointestinal solutions division, delves into the endoscopy leader’s endoluminal robotics strategy.
By Susan Kelly • June 5, 2026 -
Dexcom buys Nutrisense; Insulet rolls out patch pump update
In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet improved the software for its latest patch pump.
By Elise Reuter • June 5, 2026 -
Deep Dive
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.
Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.
By Elise Reuter • June 4, 2026 -
Medtronic seeks clearance for Hugo surgical robot in more indications
Securing 510(k) authorization would position Medtronic to compete with Intuitive in major robotic surgery markets.
By Nick Paul Taylor • June 4, 2026 -
Edwards gets FDA approval for surgical tricuspid valve
Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.
By Susan Kelly • June 3, 2026 -
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.
By Elise Reuter • June 3, 2026